These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 9690817

  • 1. Chemopreventive agents: protease inhibitors.
    Kennedy AR.
    Pharmacol Ther; 1998 Jun; 78(3):167-209. PubMed ID: 9690817
    [Abstract] [Full Text] [Related]

  • 2. Proteases, protease inhibitors and radiation carcinogenesis.
    Kennedy AR.
    Int J Radiat Biol; 2023 Jun; 99(6):882-890. PubMed ID: 34325613
    [Abstract] [Full Text] [Related]

  • 3. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.
    Kennedy AR.
    Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508
    [Abstract] [Full Text] [Related]

  • 4. Bowman-Birk inhibitors from legumes as colorectal chemopreventive agents.
    Clemente A, Arques Mdel C.
    World J Gastroenterol; 2014 Aug 14; 20(30):10305-15. PubMed ID: 25132747
    [Abstract] [Full Text] [Related]

  • 5. Biological significance of polymorphism in legume protease inhibitors from the Bowman-Birk family.
    Clementea A, Domoney C.
    Curr Protein Pept Sci; 2006 Jun 14; 7(3):201-16. PubMed ID: 16787260
    [Abstract] [Full Text] [Related]

  • 6. Prevention of carcinogenesis by protease inhibitors.
    Kennedy AR.
    Cancer Res; 1994 Apr 01; 54(7 Suppl):1999s-2005s. PubMed ID: 8137328
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.
    Armstrong WB, Kennedy AR, Wan XS, Atiba J, McLaren CE, Meyskens FL.
    Cancer Epidemiol Biomarkers Prev; 2000 Jan 01; 9(1):43-7. PubMed ID: 10667462
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Protease Inhibitors from Plants as Therapeutic Agents- A Review.
    Cid-Gallegos MS, Corzo-Ríos LJ, Jiménez-Martínez C, Sánchez-Chino XM.
    Plant Foods Hum Nutr; 2022 Mar 01; 77(1):20-29. PubMed ID: 35000105
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
    Wan XS, Serota DG, Ware JH, Crowell JA, Kennedy AR.
    Nutr Cancer; 2002 Mar 01; 43(2):167-73. PubMed ID: 12588697
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-carcinogenic soyabean Bowman-Birk inhibitors survive faecal fermentation in their active form and do not affect the microbiota composition in vitro.
    Marín-Manzano MC, Ruiz R, Jiménez E, Rubio LA, Clemente A.
    Br J Nutr; 2009 Apr 01; 101(7):967-71. PubMed ID: 19353764
    [Abstract] [Full Text] [Related]

  • 20. Intestinal epithelial cells contain a high molecular weight protease subject to inhibition by anticarcinogenic protease inhibitors.
    Habres JM, Billings PC.
    Cancer Lett; 1992 Apr 15; 63(2):135-42. PubMed ID: 1562990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.